✦ LIBER ✦

Efficacy and safety of auranofin in patients with active early rheumatoid arthritis

✍ Scribed by Mansho Itokazu; Matsunaga Takanobu; Yoshifumi Oshita

Book ID: 116096298
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 609 KB
Volume: 17
Category: Article
ISSN: 0149-2918
DOI: 10.1016/0149-2918(95)80007-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of auranofin in

The efficacy and safety of auranofin in the treatment of juvenile rheumatoid arthritis

✍ Roberto Marcolongo; Alessandro Mathieu; Riccarda Pala; Nicola Giordano; Antonell 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Efficacy and safety of bucillamine, ad-p

Efficacy and safety of bucillamine, ad-penicillamine analogue, in patients with active rheumatoid arthritis

✍ Naoya Sekiguchi; Hideto Kameda; Koichi Amano; Tsutomu Takeuchi 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 388 KB

Efficacy, safety and tolerability of lum

Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis

✍ P. Geusens; R. Alten; J. Rovensky; V.S. Sloan; G. Krammer; G. Kralidis; P. Richa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Pharmacokinetics, safety, and efficacy o

Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis

✍ Michael E. Weinblatt; Joel M. Kremer; Jonathan S. Coblyn; Agnes L. Maier; Simon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Efficacy and safety of tacrolimus in 101

Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis

✍ Mariko Kitahama; Hiroshi Okamoto; Yumi Koseki; Eisuke Inoue; Hirotaka Kaneko; At 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 344 KB

The efficacy and safety of leflunomide i

The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year followup study

✍ J. R. Kalden; M. Schattenkirchner; H. Sörensen; P. Emery; C. Deighton; B. Rozman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t